Singular effects of PPAR agonists on nonalcoholic fatty liver disease of diet-induced obese mice-Reference-Cited by-同舟云学术

Singular effects of PPAR agonists on nonalcoholic fatty liver disease of diet-induced obese mice

Published:2015-04 Issue: Volume:127 Page:73-81
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Barbosa-da-Silva Sandra,Souza-Mello Vanessa,Magliano D'Angelo Carlo,Marinho Thatiany de Souza,Aguila Marcia Barbosa,Mandarim-de-Lacerda Carlos Alberto

Funder

National Council for Science and Technology

Rio de Janeiro Foundation for Research

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference38 articles.

1. Hepatic insulin resistance and nonalcoholic fatty liver disease;Aguila,2010

2. PPARs and metabolic syndrome;Chen;PPAR Res.,2014

3. Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons;Tenenbaum;Cardiovasc. Diabetol.,2005

4. Role of peroxisome proliferator-activated receptor {delta}/{beta} in hepatic metabolic regulation;Liu;J. Biol. Chem.,2011

5. Beneficial effects of rosuvastatin on insulin resistance, adiposity, inflammatory markers and non-alcoholic fatty liver disease in mice fed on a high-fat diet;Fraulob;Clin. Sci. (Lond.),2012

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current strategies for nonalcoholic fatty liver disease treatment (Review);International Journal of Molecular Medicine;2024-08-08

2. Effects of In Utero PFOS Exposure on Epigenetics and Metabolism in Mouse Fetal Livers;Environmental Science & Technology;2023-09-27

3. Emerging therapeutic options for non-alcoholic fatty liver disease: A systematic review;World Journal of Hepatology;2023-08-27

4. Peroxisome proliferator-activated receptors as targets to treat metabolic diseases: Focus on the adipose tissue, liver, and pancreas;World Journal of Gastroenterology;2023-07-14

5. Peroxisome proliferator-activated receptors-alpha and gamma synergism modulate the gut-adipose tissue axis and mitigate obesity;Molecular and Cellular Endocrinology;2023-02